首页> 外文OA文献 >POS-375 AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: EVIDENCE FOR ELIMINATION OF DAILY PREDNISONE THERAPY AND REDUCTION IN GLUCOCORTICOID-RELATED TOXICITY FROM THE PHASE 3 ADVOCATE TRIAL

【2h】

POS-375 AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: EVIDENCE FOR ELIMINATION OF DAILY PREDNISONE THERAPY AND REDUCTION IN GLUCOCORTICOID-RELATED TOXICITY FROM THE PHASE 3 ADVOCATE TRIAL

机译：POS-375 Avacopan在ANCA相关的血管炎：消除每日泼尼松治疗和降低糖皮质激素相关毒性的证据来自第3阶段倡导审判

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
D. Jayne; P. Bekker; J. Campbell; T. Schall;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: EVIDENCE FOR ELIMINATION OF DAILY PREDNISONE THERAPY AND REDUCTION IN GLUCOCORTICOID-RELATED TOXICITY FROM THE PHASE 3 ADVOCATE TRIAL [J] . D. Jayne, P. Bekker, J. Campbell, Kidney International Reports . 2021,第4期

机译：Anca相关血管炎中的阿维泮：从第3阶段倡导审判中消除日常泼尼松治疗和降低糖皮质激素相关毒性的证据
2. A RANDOMIZED PHASE 3 TRIAL EVALUATING THE SAFETY AND EFFICACY OF AVACOPAN IN PATIENTS WITH NEW OR RELAPSING ANCA-ASSOCIATED VASCULITIS [J] . Merkel Peter, Jayne David, Harigai Masayoshi, Rheumatology . 2019,第Suppla2期

机译：一种随机相3试验评估阿维加潘在患有新的或复发的ANCA相关血管炎的患者中的安全性和疗效
3. Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis [J] . Jayne David R. W., Bruchfeld Annette N., Harper Lorraine, Journal of the American Society of Nephrology: JASN . 2017,第9期

机译：C5A受体抑制剂阿瓦科帕在ANCA相关血管炎的随机试验
4. Long-term outcomes of daily oral vs. pulsed intravenous cyclophosphamide in a non-trial setting in ANCA-associated vasculitis [O] . Jonathan La-Crette, Jeremy Royle, Peter C Lanyon, -1

机译：在非试验环境中每日口服或脉冲静脉注射环磷酰胺的长期结果与ANCA相关的血管炎
5. 326. A RANDOMIZED PHASE 3 TRIAL EVALUATING THE SAFETY AND EFFICACY OF AVACOPAN IN PATIENTS WITH NEW OR RELAPSING ANCA-ASSOCIATED VASCULITIS [O] . Peter Merkel, David Jayne, Masayoshi Harigai, 2019

机译：326.随机阶段3试验评估阿维泮在新的或复发的ANCA相关血管炎患者中的安全性和功效

POS-375 AVACOPAN IN ANCA-ASSOCIATED VASCULITIS: EVIDENCE FOR ELIMINATION OF DAILY PREDNISONE THERAPY AND REDUCTION IN GLUCOCORTICOID-RELATED TOXICITY FROM THE PHASE 3 ADVOCATE TRIAL

著录项

相似文献

相关主题

期刊订阅